Idan Ben Horin
Idan Ben Horin received his MD degree from the Hebrew University of Jeruslaem (Israel). In his thesis he investigated the role of NFκB in the development of meningiomas. He completed his residency in Medical Oncology at the Tel-Aviv Sourasky Medical Center (Israel), where his research focused on the characterization of T cells in primary brain tumors. Idan joined the group as a PhD candidate in 2018. In his thesis project he is studying the effects of CAR-engineered immune cells in humanized mouse models.
Anita Bhatti received her Master's degree in Biomedicine from the University of Mainz. In her doctoral studies, also at the University of Mainz, she evaluated CAR-engineered T cells as a tool for adoptive cellular therapy of non-small cell lung cancer. Anita joined the group as a postdoctoral fellow in 2019, investigating strategies to modulate the tumor microenvironment and endogenous antitumor immune responses with genetically modifed lymphocytes.
Malena Bodden received her Master’s degree in Biomedical Science from the University of Marburg. In her Master’s thesis she investigated the mRNA and miRNA profile of macrophages upon stimulation with pro- and anti-inflammatory cytokines in the context of eosinophilic airway inflammation. Malena joined the group as a PhD student in 2017. In her thesis project she is developing genetically engineered NK cells for cancer immunotherapy.
Thorsten Geyer obtained his Diploma in Biology from the University of Mainz. He joined the group as a technician in 1998. Thorsten also serves as the Safety Officer of the Georg-Speyer-Haus.
Ines Kühnel received her Master’s degree in Chemistry from the Technical University of Darmstadt. In her doctoral studies at the Institute for Molecular Medicine in Frankfurt am Main, she evaluated the function, expression and regulation of the human immunoreceptor NKp65 during innate lymphoid cell development. Ines joined the group as a postdoctoral fellow in 2021, investigating peripheral blood and ex vivo differentiated NK cells and genetically modified variants thereof.
Maren Prüfer received her Master’s degree in Biology with specialization in Biomedicine from the University of Gießen. During her Master's thesis at Leiden University Medical Center (Netherlands) she established a system for CRISPR/Cas9-mediated integration of CARs into the TRAC locus of primary T cells. Maren joined the group as a PhD student in 2021. In her thesis project she is arming NK cells for immunotherapy against acute myeloid leukemia.
Jasmin Röder received her Master’s degree in Biology from the University of Mainz. In her Master’s thesis she contributed to the development of an autochthonous mouse model of non-small cell lung cancer (NSCLC) for the evaluation of CAR-engineered T cells. Jasmin joined the group as a PhD student in 2017. In her thesis project she is establishing innovative mouse breast cancer models to investigate the antitumor activity of NK cells.
Jordi Pfeifer Serrahima
Jordi Pfeifer Serrahima joined the group in 2019 to work on his Master’s thesis focusing on the generation and functional characterization of bispecific antibodies that redirect cytotoxic lymphocytes to tumor cells. Since receiving his Master's degree in Molecular Biotechnology from the Technical University of Darmstadt, Jordi is continuing this work as a PhD student.
Anne Scherer received her Master's degree in Biomedicine from the University of Mainz. In her Master’s thesis she established a qRT-PCR-based assay for the detection of oncogenic driver mutations in tumor-derived exosomes to select non-small cell lung cancer patients for targeted therapy. Anne joined the group as a PhD student in 2019. In her thesis project she is developing novel bispecific antibodies for tumor targeting.
Barbara Uherek received her training as a licensed medical technical assistant in Würzburg. She initially joined the group as a technician in 1999, but left in 2002 to start a family and take care of her children. After this parental leave, Barbara returned to the group in 2010.